Supply chain, logistics

UK consortium lands grant to construct digital supply chain

30-Aug-2021 By Jenni Spinner

FarmaTrust is helping assemble a collective of public and private firms working on solutions for smart manufacturing and creating medicines of the future.

WashU report highlights vulnerabilities in US pharma supply chain

24-Aug-2021 By Jenni Spinner

According to the study, the country’s overreliance on pharmaceutical ingredients manufactured in overseas factories threatens national security and health.

3D tablet printing needs the right excipient: DFE Pharma

18-Aug-2021 By Jenni Spinner

The excipients specialist shares findings from its research into the ins and outs of 3D powder bed printed tablets and how it can benefit drug development.

Secure pharma supply chain requires connections, information

18-Aug-2021 By Jenni Spinner

A representative from Clarivate explains how supply chain vulnerabilities can hurt stakeholders, including patients—and how one solution can close the gap.

cphi north america 2021

Pharma event welcomes industry professionals ‘keen to meet’

04-Aug-2021 By Jenni Spinner

Producers of CPhI North America 2021 offer a glimpse at programming, including sessions on COVID-19 challenges, supply chain issues, and more key topics.

cphi north america 2021

Report: expect the future of US pharma market to be ‘exciting’

04-Aug-2021 By Jenni Spinner

An industry study from the producer of CPhI North America shows the pandemic and other factors are contributing to a very dynamic pharmaceutical market.

Pharmaceutical industry must fix broken supply chain: Phlow

03-Aug-2021 By Jenni Spinner

A leader from the company says to ensure medicines keep reaching the patients that need them, the industry must revamp outdated technologies and techniques.

Personalized medicine requires complex supply chains: Marken

26-Jul-2021 By Jenni Spinner

A clinical trial logistics expert discusses specialized concerns involved in transporting cell and gene products and other personalized medicine items.

CPHI NORTH AMERICA 2021

M&A activity vigorous in CDMO arena: CPhI

26-Jul-2021 By Jenni Spinner

An expert speaking during the industry event offers insight and perspective on the flurry of CDMO deal-making in recent months, and what might lie ahead.

Biden executive order could impact pharmaceutical industry

13-Jul-2021 By Jenni Spinner

US President Joe Biden singled out the pharmaceutical industry in his recently issued Executive Order on Promoting Competition in the American Economy.

People on the Move: July 2021

08-Jul-2021 By Jenni Spinner

This month’s news on hires, promotions, acquisitions, and expansions includes items about Javara, Elligo, Lonza, Yourway, Medable, and other notable firms.

CPHI NORTH AMERICA

Look for ‘supercharged’ collaboration in coming months: CPhI

28-Jun-2021 By Jenni Spinner

As the industry begins coming out of the COVID-19 pandemic, experts advise keeping an eye on growth and partnership opportunities in the US pharma market.

DCAT Week 2021 to take on industry education, innovation

24-Jun-2021 By Jenni Spinner

The annual event (scheduled July 12-16 online) will feature educational sessions, presentations, and networking opportunities for drug manufacturing pros.

Azzur opens new on-demand cleanroom facility in California

03-Jun-2021 By Jenni Spinner

The company’s Azzur Cleanrooms on Demand division has established another facility in Vista, a city in the San Diego Area, for life-sciences operations.

People on the Move: June 2021

02-Jun-2021 By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

COVID-19 pandemic fueled growth for CDMO market: CPhI Discover

27-May-2021 By Jenni Spinner

A panel of experts at the online pharma event discussed how the pandemic created opportunities for the field but could also lead to significant challenges.

Tech Innovations: May 2021

19-May-2021 By Jenni Spinner

This month’s roundup of new equipment, technology partnerships, and other news includes items from Ajinomoto, Elligo, Syneos, ACD/Labs and other companies.

Online HPAPI Summit takes on key pharma ingredients topics

19-May-2021 By Jenni Spinner

The virtual event (scheduled June 22-24) will feature presentations from Bayer, Merck, GSK, Novartis, Takeda, FDA, WHO, and other notable organizations.

Artificial intelligence can elevate pharma manufacturing

18-May-2021 By Jenni Spinner

According to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed.

Could synthetic biology solutions fix supply chain challenges?

11-May-2021 By Jenni Spinner

An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.

CPhI survey: pharma leaders optimistic about the future

03-May-2021 By Jenni Spinner

According to a recent survey of executives conducted by CPhI, COVID-19’s impact is driving manufacturing and CDMOs are fueling industry growth.

Direct-to-patient services keep trials moving forward

22-Apr-2021 By Jenni Spinner

Leaders from AmerisourceBergen's World Courier and Lash Group tell how bringing trial supplies and services to patients can boost recruitment and retention.

Decentralized trials call for supply chain flexibility: Marken

12-Apr-2021 By Jenni Spinner

Leaders from the supply chain solutions company share their thoughts on challenges associated with virtual and hybrid trials, and the COVID-19 pandemic.

Severe winter storm wrought havoc on pharma supply chain

08-Apr-2021 By Jenni Spinner

An expert from FourKites shares impacts of the February storm that hit Texas and other parts of North America, and lessons can be learned from the event.

Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies

25-Mar-2021 By Jane Byrne

A US court’s recent decision to find in favor of Sanofi and invalidate Amgen's broad antibody patent claims has biotech manufacturers concerned about how to preserve their IP.

Sagent issues voluntary recall of phenylephrine hydrochloride vials

15-Mar-2021 By Jenni Spinner

The company is recalling 10 mg/mL vials of phenylephrine hydrochloride due to potential lack of sterility assurance in several lots of the product.

Thermo Fisher Scientific expands DTP trial service offerings

11-Mar-2021 By Jenni Spinner

The direct-to-patient service is designed to support trials and help to minimize trial length and costs, while boosting enrollment and participation rates.

Lonza expands solid-form services at Oregon facility

01-Mar-2021 By Jenni Spinner

The company has increased capabilities at its Bend, Oregon location, including its SimpliFiH Solutions first-in-human services for small-molecule drugs.

Covectra launches StellaGuard ‘smart’ label anti-counterfeiting

22-Feb-2021 By Jenni Spinner

The on-pack technology enables consumers, retailers and others to harness mobile devices in order to verify the authenticity of pharmaceutical products.

On-demand capabilities help drug developers in a pinch

18-Feb-2021 By Jenni Spinner

With demand for fast-tracking therapies, vaccines and other products increasing, companies like Azzur Group offer the ability to add capabilities quickly.

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

18-Feb-2021 By Jane Byrne

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

Blockchain could accelerate drug development: Bloqcube

15-Feb-2021 By Jenni Spinner

With pharma firms seeking solutions to get products in the hands of patients faster, one company believes blockchain technology could provide answers.

PwC joins Medicines Manufacturing Innovation Centre

11-Feb-2021 By Jenni Spinner

The global professional services firm has signed on the newest partner in the collaboration, aimed toward promoting innovation in pharma manufacturing.

WuXi STA to buy Bristol Myers Squibb’s Couvet, Switzerland manufacturing facility

02-Feb-2021 By Rachel Arthur

WuXi STA will purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland: giving the CDMO its first facility in Europe.

Radiopharmaceuticals attract increasing interest: SpectronRx

26-Jan-2021 By Jenni Spinner

While the field is decades old, according to one specialist, more and more industry professionals are noting its diagnostic and treatment potential.

‘Cognitive’ supply chain approach boosts safety, efficiency: FourKites

21-Jan-2021 By Jenni Spinner

A leader from the supply-chain specialist explains vulnerabilities and challenges unique to pharma, and how professionals can safeguard and streamline.

Continuus lands $69.3m US drug manufacturing contract

21-Jan-2021 By Jenni Spinner

The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions.

Sanofi unveils EUROAPI as name of new API company

14-Jan-2021 By Jenni Spinner

The global pharmaceutical firm expects big things from its newly formed active pharmaceutical ingredients company, to be led by new CEO Karl Rotthier.

Fight against pharma counterfeiting must go deeper: TruTag

13-Jan-2021 By Jenni Spinner

A leader from the anti-counterfeit solutions firm says that while packaging-level efforts may have an effect, on-dose technology is worth a closer look.

LA customs agents seize $19m in counterfeit Viagra pills

13-Jan-2021 By Jenni Spinner

Authorities discovered the fake Pfizer erectile-dysfunction tablets in one of three cargo containers full of fraudulent goods, recently arrived from China.

Lonza scientific team on the hunt for pharma fakery

13-Jan-2021 By Jenni Spinner

The company’s Forensic Chemistry Group comprises a collection of technical professionals using their respective talents to detect and thwart counterfeiting.

Global alliance unites pharma pros to battle counterfeiting

13-Jan-2021 By Jenni Spinner

Fight the Fakes gathers manufacturers and other stakeholders to brainstorm on ways to combat falsified medicines and safeguard the world’s medicine supply.

Counterfeit Janssen HIV drug discovered in US pharmacies

13-Jan-2021 By Jenni Spinner

The pharmaceutical firm reports a counterfeit version of its Symtuza HIV treatment has been found and pulled from shelves at three American pharmacies.

Pharmaceutical firms warming up to outsourcing: ReAgent

07-Jan-2021 By Jenni Spinner

A leader from the chemical manufacturing firm notes pharma companies are showing increased interest in contracting out their manufacturing functions.

Ingredients, innovation and a need for speed: what’s in store for 2021

23-Dec-2020 By Jenni Spinner

Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.

Supply chain woes can lead to billion-dollar problems: Cloudleaf

23-Dec-2020 By Jenni Spinner

A new survey from the supply-chain analysis company revals inefficiencies, inaccurate data and other flaws can be costly in terms of revenue, reputation and patient lives.

COVID-19 response platform expands reach across US

22-Dec-2020 By Jenni Spinner

The GoGetTested response operating system, to date used to administer more than 200,000 tests, now will scale to include health systems in more states.

Stay on top of your pharma supply chain in 2021: PCI

17-Dec-2020 By Jenni Spinner

According to an executive from the drug development services company, pharma professionals should pay close attention to supply chain continuity and safety in the coming year.

Looking back, thinking ahead: industry leaders talk trends

16-Dec-2020 By Jenni Spinner

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

Data explosion leads to opportunities, obstacles: ACD/Labs

16-Dec-2020 By Jenni Spinner

A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.